Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”

Khalaf Kridin; Ralf J. Ludwig

doi:10.1016/j.jaad.2024.06.100

Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”

^*Corresponding author for this work

Original language	English
Journal	Journal of the American Academy of Dermatology
Volume	91
Issue number	6
Pages (from-to)	e169-e170
ISSN	0190-9622
DOIs	https://doi.org/10.1016/j.jaad.2024.06.100
Publication status	Published - 12.2024

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)
Centers: Center for Research on Inflammation of the Skin (CRIS)

DFG Research Classification Scheme

2.21-05 Immunology
2.22-19 Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaad.2024.06.100

Cite this

@article{5aad5c2f88fe4db187e7f7bd6b40b5df,

title = "Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”",

author = "Khalaf Kridin and Ludwig, {Ralf J.}",

year = "2024",

month = dec,

doi = "10.1016/j.jaad.2024.06.100",

language = "English",

volume = "91",

pages = "e169--e170",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

number = "6",

}

TY - JOUR

T1 - Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma

T2 - A retrospective cohort study”

AU - Kridin, Khalaf

AU - Ludwig, Ralf J.

PY - 2024/12

Y1 - 2024/12

UR - http://www.scopus.com/inward/record.url?scp=85204562624&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2024.06.100

DO - 10.1016/j.jaad.2024.06.100

M3 - Letters

C2 - 39116944

AN - SCOPUS:85204562624

SN - 0190-9622

VL - 91

SP - e169-e170

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 6

ER -

Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”

Research Areas and Centers

DFG Research Classification Scheme

UN SDGs

Access to Document

Other files and links

Cite this